Figure 1. Adverse outcome pathway and Selected key events and adverse outcomes
Figure 2. Possible genetic and epigenetic pathways linking occupational/environmental exposures and adverse effects
Table 1. Definitions used in mechanistic frameworks for predicting and assessing toxicity
Table 2. Guide to assessing genetic and epigenetic data for risk assessment
Table 3. External links about AOP sources
참고문헌
- Allen TEH, Goodman JM, Gutsell S, Russell PJ. Defining molecular initiating events in the adverse outcome pathway framework for risk assessment. Chem Res Toxicol 2014;27(12):2100-2112(DOI: 10.1021/tx500345j)
- American Cancer Society(ACS). Known and probable human carcinogens. [serial online] 2018 [Accessed 2019 March 20]. Available from: URL:https://www.cancer.org/cancer/cancer-causes/general-info/known-and-probable-human-carcinogens.html
- Andersen ME, Al-Zoughool M, Croteau M, Westphal M, Krewski D. The future of toxicity testing. J Toxicol Environ Health B 2010;13:163-196(doi: 10.1080/10937404.2010.483933.)
- Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, et al. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 2010;29:730-741(doi: 10.1002/etc.34.)
- Anna Bal-Pricea, Pamela J. Lein, Kimberly P. Keil, Sunjay Sethi, Timothy Shafer, et al. Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. Neuro Toxicology 2017;59:240-255(doi: 10.1016/j.neuro.2016.05.010.)
- Balls M. Why modification of the LD50 test will not be enough. Lab Anim 1991;25:198-206 https://doi.org/10.1258/002367791780808310
- Bell J, Healey N. The causes of major hazard incidents and how to improve risk control and health and safety management: a review of the existing literature. Buxton, Health and Safety Laboratory, 2006
- Benowitz NL. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc 2014;11:231-235(doi: 10.1513/AnnalsATS.201312-433PS)
- BeruBe K. Medical waste tissues-breathing life back into respiratory research. Altern. Lab Anim 2013;41(6):429-434 https://doi.org/10.1177/026119291304100604
- Bessems JG, Loizou G, Krishnan K, Clewell HJ, Bernasconi C, et al. PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA-EURL ECVAM ADME workshop. Regul Toxicol Pharmacol 2014;68:119-139(doi: 10.1016/j.yrtph.2013.11.008.)
- Boekelheide K, Andersen ME. A mechanistic redefinition of adverse effects-a key step in the toxicity testing paradigm shift. ALTEX 2010;27:243-252 https://doi.org/10.14573/altex.2010.4.243
- Bollati V, Baccarelli, A. Environmental epigenetics. Heredity (Edinib) 2010;105(1):105-112(doi: 10.1038/hdy.2010.2.)
- Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes? J Public Health Policy 2011;32:16-31(doi: 10.1057/jphp.2010.41.)
- Carpenter DO, Arcaro K, Spink DC. Understanding the human health effects of chemical mixtures. Environ Health Perspect 2002;110(Suppl 1):25-42 https://doi.org/10.1289/ehp.02110s125
- Celli B, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22:268-273 https://doi.org/10.1183/09031936.03.00075102
- Chapman K, Creton S, Kupferschmidt H, Bond GR, Wilks MF, et al., The value of acute toxicity studies to support the clinical management of overdose and poisoning: a cross-discipline consensus. Regul Toxicol Pharmacol 2010;58(3):354-359 https://doi.org/10.1016/j.yrtph.2010.07.003
- ChemSafetyPro. Chemical risk assessment: overview and examples. [serial online] 2018 [Accessed 2019 March 20]. Available from: URL:https://www.chemsafetypro.com/Topics/CRA/introduction_to_chemical_risk_assessment_overview_principles.html
- Clewell H. Use of mode of action in risk assessment: past, present, and future. Regul Toxicol Pharmacol 2005;42:3-14 https://doi.org/10.1016/j.yrtph.2005.01.008
- Clewell HJ, Gentry PR, Gearhart JM, Allen BC, Andersen ME. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. Chemosphere 1995;31(1):2561-2578 https://doi.org/10.1016/0045-6535(95)00124-Q
- Clippinger AJ, Allen D, Jarabek AM, Corvaro M, Gaca M, et al., Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: an international workshop report. Toxicol in vitro 2018a;48:53-70 (doi: 10.1016/j.tiv.2017.12.011.)
- Clippinger AJ, Allen D, Behrsing H, BeruBe KA, Bolger MB, et al. Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity. Toxicol in Vitro 2018b;52:131-145(doi: 10.1016/j.tiv.2018.06.009.)
- Cohen SM, Arnold LL. Chemical carcinogenesis. Toxicol Sci 2011;120(Suppl 1):S76-92. https://doi.org/10.1093/toxsci/kfq365
- Collins FS, Gray GM, Bucher JR. Toxicology. Transforming environmental health protection. Science 2008;319:906-907 https://doi.org/10.1126/science.1154619
- Duffus JH, Nordberg M, Templeton DM. Glossary of terms used in toxicology. 2nd edition. Research Triangle Park, Pure and Applied Chemistry 2007; p. 1153
- Edwards SW, Tan YM, Villeneuve DL, Meek ME, Mc Queen CA. Adverse outcome pathways-organizing toxicological information to improve decision making. J Pharmacol Exp Ther 2016;356:170-181 https://doi.org/10.1124/jpet.115.228239
- European chemicals agency(ECHA). Weight of evidence. [serial online] 2018 [Accessed 2019 March 20]. Available from: URL:https://echa.europa.eu/support/registration/how-to-avoid-unnecessary-testingon-animals/weight-of-evidence
- Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, et al. Strengthening the reporting of observational studies in epidemiology-Molecular Epidemiology STROBE-ME: an extension of the STROBE statement. J Clin Epidemiol 2011;64(12):1350-1363 https://doi.org/10.1016/j.jclinepi.2011.07.010
- Gerloff K, Landesmann B, Worth A, Munn S, Palosaari T, et al. The Adverse Outcome Pathway approach in nanotoxicology. Comput Toxicol 2017;1:3-11 https://doi.org/10.1016/j.comtox.2016.07.001
- Gollapudi BB, Johnson GE, Hernandez LG, Pottenger LH, Dearfield KL, et al. Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. Environ Mol Mutagen 2013;54:8-18 https://doi.org/10.1002/em.21727
- Groh KJ, Carvalho RN, Chipman JK, Denslow ND, Halder M, et al. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology. Chemosphere 2015;120:764-777 https://doi.org/10.1016/j.chemosphere.2014.09.068
- Hartung T, McBride M. Food for Thought ... on mapping the human toxome. ALTEX 2011;28:83-93 https://doi.org/10.14573/altex.2011.2.083
- Hernandez AF, Tsatsakis AM. Human exposure to chemical mixtures: challenges for the integration of toxicology with epidemiology data in risk assessment. Food Chem Toxicol 2017;103:188-193(doi: 10.1016/j.fct.2017.03.012.)
- Hill AB. The Environment and disease: Association or caution? Proc R Soc Med 1965;58:295-300
- IARC. Agents classified by the IARC monographs, volumes 1-122 [serial online] 2018 [Accessed 2019 March 20]. Available from: URL:https://monographs.iarc.fr/agents-classified-by-the-iarc/
- IOMC. Manual for the public health management of chemical incidents. Geneva, WHO, 2009
- Jarabek AM. The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches. Toxicology Letters 1995;79(1-3):171-184 https://doi.org/10.1016/0378-4274(95)03368-U
- Jefferson M, Chung PWH, Kletz TA. Learning the lessons from past accidents. London, IChemE Services:1997. p. 217-226
- Jennings P. Stress response pathways, toxicity pathways and adverse outcome pathways. Arch Toxicol 2013;87(1):13-14 https://doi.org/10.1007/s00204-012-0974-4
- Kang DS, Yang JH, Kim HS, Koo BK, Lee CM, et al. Application of the Adverse Outcome Pathway Framework to Risk Assessment for Predicting Carcinogenicity of Chemicals. J Cancer Prev 2018; 23(3):126-133 https://doi.org/10.15430/JCP.2018.23.3.126
- Kimber I, Pooleb A, Basketter DA. Skin and respiratory chemical allergy: confluence and divergence in a hybrid adverse outcome pathway. Toxicol Res 2018;7:586-605 https://doi.org/10.1039/C7TX00272F
- Kimber I, Dearmana RJ, Basketter DA, Boverhof DR. Chemical respiratory allergy: Reverse engineering an adverse outcome pathway. Toxicology 2014;318:32-39 https://doi.org/10.1016/j.tox.2014.02.001
- Korean Statistical Information Service Age specific pneumonia mortality in South Korea during 1995-2015. [serial online] 2016 [Accessed 2019 March 20]. Available from: URL:http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parmTabId=M_01_01
- Krewski D, Acosta D, Andersen M, Anderson H, Bailar JC, et al. Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 2010;13:51-138 https://doi.org/10.1080/10937404.2010.483176
- Krewski D, Westphal M, Al-Zoughool M, Croteau MC & Andersen ME. New directions in toxicity testing. Annual Review of Public Health 2011;32:161-78 (doi: 10.1146/annurev-publhealth-031210-101153.)
- Langley G, Austin CP, Balapure AK, Birnbaum LS, Bucher JR. et al. The Humane Society Institute for Science and Policy - Animal Studies Repository 2015 Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research
- Leem JH, Chung KH. Combined approaches using adverse outcome pathways and big data to find potential diseases associated with humidifier disinfectant. Environ Health Toxicol 2017;32:e2017003 https://doi.org/10.5620/eht.e2017003
- Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, et al. Adverse outcome pathways: Opportunities, limitations and open questions. Arch Toxicol 2017;91(3):477-505
- MacKay C., Davies M, Summerfield V, Maxwell G. From Pathways to People: Applying the Adverse Outcome Pathway(AOP) for skin sensitization to risk assessment. Altex-Alter Animal Exper 2013;30(4):473-486
- McNeill A. Should clinicians recommend e-cigarettes to their patients who smoke? Yes. Ann Fam Med 2016;14:300-301(doi: 10.1370/afm.1962.)
- Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, et al. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol 2014;34(1):1-18 https://doi.org/10.1002/jat.2949
- Meernik C, Goldstein AO. Should clinicians recommend e-cigarettes to their patients who smoke? No. Ann Fam Med 2016;14:302-303 https://doi.org/10.1370/afm.1961
- Murti CK. Biological effects of chemical disasters: human victims. In: Bourdeau P, Green G, editors. eds. Methods for assessing and reducing injury from chemical accidents. Chichester, Wiley, 1989
- Myatt GJ, Ahlberg E, Akahori Y, Allen D, Amberg A, et al. In silico toxicology protocols. Regul Toxicol Pharmacol 2018;96:1-17(doi: 10.1016/j.yrtph.2018.04.014.)
- National Research Council (US). Committee on Occupational Health and Safety in the Care and Use of Nonhuman Primates. Occupational health and safety in the care and use of nonhuman primates. Washington, DC, National Academies Press, 2003
- National Research Council. Toxicity testing in the 21st century: A vision and a strategy. 2007, National Academic Press: Washington, DC. 2007
- Nymark P, Kohonen P, Hongisto V, Grafstrom RC. Toxic and genomic influences of inhaled nanomaterials as a basis for predicting adverse outcome. Ann Am Thorac Soc 2018;15(2):S91-S97(doi: 10.1513/AnnalsATS.201706-478MG.)
- OECD. Guidance document on developing and assessing adverse outcome pathways. OECD Environment, Health and Safety Publications. Series on Testing and Assessment No. 184. ENV/JM/MONO (2013)6. [serial online] 2013 [Accessed 2019 March 20]. Available from: URL:http://www.oecd.org/chemicalsafety/
- OECD. Test No. 433: Acute inhalation toxicity-fixed concentration procedure. OECD Guidelines for the testing of chemicals, Section 4. 2017
- OECD. Adverse Outcome pathway knowledge base (AOP-KB). Series on Testing and Assessment No. 184. ENV/JM/MONO(2013)6. [serial online] 2018a [Accessed 2019 March 20]. Available from: URL: https://aopkb.oecd.org/background.html
- OECD. Adverse outcome pathways, molecular screening and toxicogenomics. [serial online] 2018b [Accessed 2019 March 20]. Available from: URL:http://www.oecd.org/chemicalsafety/testing/adverse-outcome-pathways-molecular-screening-and-toxic-ogenomics.htm
- OECD portal site(topics_adverse outcome pathways, molecular screening and toxicogenomics) [serial online] 2019 [Accessed 2019 March 20]. Available from:https://www.oecd.org/chemicalsafety/testing/adverse-outcome-pathways-molecular-screening-and-toxicogenomics.htm
- OECD. Proposal for a template, and guidance on developing and assessing the completeness of adverse outcome pathways. Paris, OECD Publishing, 2012
- OECD. Users' handbook supplement to the guidance document for developing and assessing adverse outcome pathways. Paris, OECD Publishing, 2016
- Oliveira PA, Colaco A, Chaves R, Guedes-pinto H, De-La-Cruz PLF, et al. Chemical carcinogenesis. An Acad Bras Cienc 2007;79:593-616 https://doi.org/10.1590/S0001-37652007000400004
- Pletz J, Sanchez-Bayo F, Tennekes HA. Dose-response analysis indicating time-dependent neurotoxicity caused by organic and inorganic mercuryimplications for toxic effects in the developing brain. Toxicology 2016;347-349:1-5(doi: 10.1016/j.tox.2016.02.006.)
- Scheffler S, Dieken H, Krischenowski O, Aufderheide M. Cytotoxic evaluation of e-liquid aerosol using different lung-derived cell models. Int J Environ Res Public Health 2015;12:12466-12474 https://doi.org/10.3390/ijerph121012466
- Scheffler S, Dieken H, Krischenowski O, Forster C, Branscheid D, et al. Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health 2015;12:3915-3925 https://doi.org/10.3390/ijerph120403915
- Schulte PA, Whittaker C, Curran CP. Considerations for Using Genetic and Epigenetic Information in Occupational Health Risk Assessment and Standard Setting. J Occup Environ Hyg. 2015;12 Suppl 1(sup1):S69-S81.(doi:10.1080/15459624.2015.1060323.)
- Schultz TW. Adverse outcome pathways: a way of linking chemical structure to in vivo toxicological hazards. In In Silico Toxicology: Principles and Applications (ed. M.T.D. Cronin & J.C. Madden), p. 346-371. Cambridge, UK: The Royal Society of Chemistry
- Hartung T & McBride M(2011). Food for Thought on mapping the human toxome. ALTEX 2010;28:83-93 https://doi.org/10.14573/altex.2011.2.083
- Seidle T, Robinson S, Holmes T, Creton S, Prieto P, et al. Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testing. Toxicological Sciences, 2010;116(2):382-396 https://doi.org/10.1093/toxsci/kfq143
- Shivalingappa PC, Hole R, Westphal CV, Vij N. Airway exposure to e-cigarette vapors impairs autophagy and induces aggresome formation. Antioxid Redox Signal 2016;24:186-204 https://doi.org/10.1089/ars.2015.6367
- Silins I, Hogberg J. Combined toxic exposures and human health: biomarkers of exposure and effect. Int J Environ Res Public Health 2011;8:629-647 https://doi.org/10.3390/ijerph8030629
- Song JA, Park HJ, Yang MJ, Jung KJ, Yang HS, et al. Polyhexamethyleneguanidine phosphate induces severe lung inflammation, fibrosis, and thymic atrophy. Food Chem Toxicol 2014;69:267-275 https://doi.org/10.1016/j.fct.2014.04.027
- Sugimura T. Multistep carcinogenesis: a 1992 perspective. Science 1992;258:603-607 https://doi.org/10.1126/science.1411570
- Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis 2000;21:387-395 https://doi.org/10.1093/carcin/21.3.387
- Sullivan KM, Enoch SJ, Ezendam J, Roggen KEL, Cochrane S. An adverse outcome pathway for sensitization of the respiratory tract by low-molecular-weight chemicals: Building evidence to support the utility of In Vitro and In Silico methods in a regulatory context. Applied In Vitro Toxicology 2017;3(3)
- Tang S, Cui H, Yao L, Hao X, Shen Y, et al. Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease. PLoS One 2013;8(4):e62385 https://doi.org/10.1371/journal.pone.0062385
- Taylor M, Carr T, Oke O, Jaunky T, Breheny D, et al. E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol Mech Methods 2016;26(6):465-476 https://doi.org/10.1080/15376516.2016.1222473
- Terron A, Bal-Pric A, Paini A, Monnet-Tschudi F, Bennekou SH, et al. An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition. Archives of Toxicology 2018;92(1):41-82 (doi: 10.1007/s00204-017-2133-4.)
- Tollefsen KE, Scholz S, Cronin MT, Edwards SW, de Knecht J, et al. Applying Adverse Outcome Pathways(AOPs) to support Integrated Approaches to Testing and Assessment(IATA). Regul Toxicol Pharmacol 2014;70:629-640 https://doi.org/10.1016/j.yrtph.2014.09.009
- U.S. EPA. Human health risk assessment. [serial online] 2018 [Accessed 2019 March 20]. Available from: URL:https://www.epa.gov/risk/human-health-risk-assessment
- US EPA. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001FMarch. [serial online] 2005 [Accessed 2019 March 20]. Available from: URL:http://www.epa.gov/raf/publications/pdfs/CANCER_GUIDELINES_FINAL_3-25-05.PDF
- US EPA. Risk and Technology Review(RTR) Risk Assessment Methodologies: For Review by the EPA's Science Advisory Board. Case Studies - MACT I Petroleum Refining Sources Portland Cement Manufacturing(EPA-452/R-09-006). 2009
- van der Veen JW, Soeteman-Hernandez LG, Ezendam J, Stierum R, Kuper FC, et al. Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: Analysis of existing data. Crit Rev Toxicol 2014;44(7):590-599 https://doi.org/10.3109/10408444.2014.925425
- Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, et al. Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 2014a;142(2):312-320(doi: 10.1093/toxsci/kfu199.)
- Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, et al. Adverse outcome pathway development II: best practices Toxicol Sci 2014b; 142(2):321-330(doi: 10.1093/toxsci/kfu200.)
- Vinken M. The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 2013;312:158-165 https://doi.org/10.1016/j.tox.2013.08.011
- WHO. Environmental Health Criteria 240: Principles and methods for the risk assessment of chemicals in food. World Health Organization, Geneva. [serial online] 2009 [Accessed 2019 March 20]. Available from: http://www.who.int/entity/foodsafety/chem/principles/en/index.html
- Worth A, Barroso J, Bremer S, Burton J, Casati S, et al. Alternative methods for regulatory toxicology-a state-of-the-art review. European Union Reference Laboratory for Alternatives to Animal Testing(EURL ECVAM), Systems Toxicology Unit, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra, Italy. 2014
- Zbinden G, Flury-Roversi M. Significance of the LD50 test for the toxicological evaluation of chemical substances. Arch. Toxicol 1981;47(2):77-99 https://doi.org/10.1007/BF00332351
- Zheng F, Zhang MG, Song J, Chen FZ. Analysis on risk of multi-factor disaster and disaster control in oil and gas storage tank. Procedia Eng 2018;211:1058-1064 https://doi.org/10.1016/j.proeng.2017.12.110
- Zvinavashe E, van den Berg H, Soffers AE, Vervoort J, Freidig A, et al. QSAR models for predicting in vivo aquatic toxicity of chlorinated alkanes to fish. Chem Res Toxicol 2008;21:739-745(doi: 10.1021/tx700367c.)